FDA Approved: TALZENNA — Original Application (U.S. Pharmaceuticals)

View source ↗

Summary

FDA approves TALZENNA (talazoparib) in the original application for the treatment of adult patients with germline BRCA-mutated, HER2-negative locally advanced o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Talzenna (talazoparib)

Snippet

ORIG AP for TALZENNA (TALAZOPARIB)